← All companies 
Maxion Therapeutics
2 open jobs
Maxion Therapeutics has engineered a new class of biologics by harnessing knottins to modulate ion channels and G protein-coupled receptors (GPCRs). The company combines knottin technology with antibody properties to develop transformative treatments for ion channel and GPCR-driven diseases, initially focused on immunological diseases, heart disorders, and chronic pain.